Overview
Buccal Versus Vaginal Misoprostol in Surgical Termination of the First Trimester Missed Abortion in Erbil
Status:
Completed
Completed
Trial end date:
2008-03-01
2008-03-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
The purpose of this study is to determine the effectiveness of buccal misoprostol and comparing this with vaginal route of the same drug.Phase:
Phase 2Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Hawler Medical UniversityCollaborator:
NEGATIVETreatments:
Misoprostol
Criteria
Inclusion Criteria:- first trimester missed abortion
Exclusion Criteria:
- history or evidence of disorders that represent contraindication to the use of
misoprostol:
- severe pulmonary diseases
- congenital or acquired heart diseases
- glaucoma
- prolonged use of corticosteroid
- sickle cell anemia and adrenal insufficiency
- smokers
- known hypersensitivity to drugs
- any evidence of infection
- patient's refusal to participate in the study
- patients with abnormal results of investigations
- patients with previous operations on cervix like conisation, cauterization, previous
dilatation and curettage
- patients with complete abortion
- patients with severe bleeding that required emergency surgical evacuation of the
uterus
- patients with partially dissolved tablets at the site of application in both groups